March 21, 2023 02:41 PM IST

Granules India shares rise as arm concludes US FDA audit

Granules Consumer Health's packaging unit in Manassas was inspected by the US FDA from March 15-20.

Granules gets USFDA nod to market generic medication to treat high blood pressure

The company has received approval from the US Food & Drug Administration (USFDA) to market Losartan Potassium tablets in strengths of 25 mg, 50 mg, and 100 mg, Granules India said in a regulatory filing.

Granules India secures FDA nod to hypertension drug but share price falls

The company now has a total of 54 ANDA approvals from USFDA, including 52 final approvals and 2 tentative approvals.

Buy Granules India; target of Rs 355: ICICI Direct

ICICI Direct is bullish on Granules India recommended buy rating on the stock with a target price of Rs 355 in its research report dated January 28, 2023.

Granules India Consolidated December 2022 Net Sales at Rs 1,146.13 crore, up 14.98% Y-o-Y

Granules India Standalone December 2022 Net Sales at Rs 1,032.39 crore, up 16.03% Y-o-Y

Paracetamol maker Granules India posts 23% rise in Q3 profit

Consolidated profit rose to 1.24 billion rupees ($15.22 million) for the three months ended Dec. 31, from 1.01 billion rupees a year earlier.

Buy Granules India; target of Rs 400: Sharekhan

Sharekhan is bullish on Granules India has recommended buy rating on the stock with a target price of Rs 400 in its research report dated December 23, 2022.

Hold Granules India; target of Rs 400: Sharekhan

Sharekhan recommended Hold rating on Granules India with a target price of Rs 400 in its research report dated October 28, 2022.

Hot Stocks | Container Corp, Bharat Forge, Granules India can give up to 22% return in short term. Here's why

Bharat Forge, post August 2021, corrected with decreasing volumes. This tells that the stock has weak supply.

Buy Granules India; target of Rs 410: ICICI Direct

ICICI Direct is bullish on Granules India recommended buy rating on the stock with a target price of Rs 410 in its research report dated October 25, 2022.

Granules India Consolidated September 2022 Net Sales at Rs 1,150.73 crore, up 29.54% Y-o-Y

Granules India Standalone September 2022 Net Sales at Rs 963.58 crore, up 36.93% Y-o-Y

Trade Spotlight | What should you do with Granules India, Bharti Airtel, India Cements on Monday?

On September 30, India Cements and Granules India outdid the market and were the biggest gainers in the futures & options segment

Hot Stocks | Here is why you should bet on Granules India, DLF for short term

Sameet Chavan of Angel One advises traders to keep a close tab on global developments and says any favourable cues will certainly provide the much-needed push to the domestic market

Top 10 trading ideas by experts for next 3-4 weeks as bears rule Dalal Street

One should avoid trading aggressively till the time market stabilises from this turbulence, Sameet Chavan of Angel One advises

Hold Granules India; target of Rs 332: Sharekhan

Sharekhan recommended Hold rating on Granules India with a target price of Rs 332 in its research report dated August 10, 2022.

Buy Granules India; target of Rs 370: Motilal Oswal

Motilal Oswal is bullish on Granules India recommended buy rating on the stock with a target price of Rs 370 in its research report dated August 10, 2022.

Granules India Consolidated June 2022 Net Sales at Rs 1,019.56 crore, up 19.97% Y-o-Y

Granules India Standalone June 2022 Net Sales at Rs 921.36 crore, up 25.85% Y-o-Y

USFDA issues six observations for Granules Pharma's US facility

USFDA completed an inspection of the facility of Granules Pharmaceuticals on July 22.

Trade Spotlight | What should you do with Adani Total Gas, Granules India, Bank of Baroda on Tuesday?

Granules India witnessed positive divergence between the prices and RSI indicator. The divergence is followed by breakout in RSI as well which indicates a strong momentum in the stock prices.

Trade Spotlight | What should you do with Granules India, Welspun Corp, JK Lakshmi Cement on Monday?

Currently JK Lakshmi Cement is well placed above 20, 50 and 100 day SMA. The daily weekly strength indicator RSI is in bullish terrain which supports rising momentum. The daily "band Bollinger" buy signal indicates increased momentum.

Accumulate Granules India; target of Rs 270: KR Choksey

KR Choksey recommended accumulate rating on Granules India with a target price of Rs 270 in its research report dated May 20, 2022.

Buy Granules India; target of Rs 300: Motilal Oswal

Motilal Oswal is bullish on Granules India recommended buy rating on the stock with a target price of Rs 300 in its research report dated May 19, 2022.